Granules USA, Inc. recalls Naproxen Sodum Tablets USP 220 mg, (Caplet), Manufactured by: Granules India Limited, Sy.No. 160/A, 161/E, 162, &174/A,
Recalled September 8, 2021 · FDA recall D-0777-2021 · Granules USA
Hazard
CGMP Deviations · FDA Class II
Units
11,450,000 tablets
Sold at
NY
Description
CGMP Deviations
Product
Naproxen Sodum Tablets USP 220 mg, (Caplet), Manufactured by: Granules India Limited, Sy.No. 160/A, 161/E, 162, &174/A, Gagillapur Village, Dundigal-Gandimalsamma Monday, Medchai-Maikhajgir District - 500043, Telangana, INDIA. NDC 62207-762-36
Manufacturer(s)
Granules USA, Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →